Skip to main content

Peer Review reports

From: An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Original Submission
31 Oct 2016 Submitted Original manuscript
10 Nov 2016 Author responded Author comments - Feifei Sun
Resubmission - Version 2
10 Nov 2016 Submitted Manuscript version 2
13 Feb 2017 Author responded Author comments - Feifei Sun
12 Dec 2016 Reviewed Reviewer Report - Craig Portell
Resubmission - Version 3
13 Feb 2017 Submitted Manuscript version 3
25 Aug 2017 Author responded Author comments - Feifei Sun
11 Apr 2017 Reviewed Reviewer Report - Feng Gao
9 Apr 2017 Reviewed Reviewer Report - Hao Wang
Resubmission - Version 4
25 Aug 2017 Submitted Manuscript version 4
7 Oct 2017 Author responded Author comments - Feifei Sun
29 Aug 2017 Reviewed Reviewer Report - Feng Gao
4 Sep 2017 Reviewed Reviewer Report - Hao Wang
Resubmission - Version 5
7 Oct 2017 Submitted Manuscript version 5
25 Nov 2017 Author responded Author comments - Feifei Sun
10 Oct 2017 Reviewed Reviewer Report - Hao Wang
Resubmission - Version 6
25 Nov 2017 Submitted Manuscript version 6
14 Dec 2017 Author responded Author comments - Feifei Sun
Resubmission - Version 7
14 Dec 2017 Submitted Manuscript version 7
Publishing
18 Dec 2017 Editorially accepted
2 Jan 2018 Article published 10.1186/s12885-017-3931-z

You can find further information about peer review here.

Back to article page